Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.

Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L.

Cancers (Basel). 2020 Sep 30;12(10):E2812. doi: 10.3390/cancers12102812.

https://pubmed.ncbi.nlm.nih.gov/33007814/